Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-254300
Filing Date
2025-10-28
Accepted
2025-10-28 19:49:42
Documents
1
Period of Report
2025-10-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 13773
  Complete submission text file 0001193125-25-254300.txt   15179
Mailing Address 3338 LANCASHIRE RD FURLONG PA 18925
Business Address
Rowland Charles A Jr (Reporting) CIK: 0001383292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 251426432

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)